Atul Pande
Director at Immunovant · 8 reported transactions in 1 company · latest trade Jul 24, 2026
Their trades
Sold | Jul 24, 2026 | Jul 24, 2026 close $39.41 → Oct 29, 2026 close $29.64. S&P 500 +4.5% over the same days. | ||
Sold | Jun 26, 2026 | Jun 26, 2026 close $38.85 → Oct 29, 2026 close $29.64. S&P 500 +5.9% over the same days. | ||
Sold | Jun 15, 2026 | Jun 15, 2026 close $33.44 → Oct 29, 2026 close $29.64. S&P 500 +2.3% over the same days. | ||
Sold | May 20, 2026 | May 20, 2026 close $35.56 → Oct 29, 2026 close $29.64. S&P 500 +4.2% over the same days. |
SoldImmunovant
$59.7K
Jul 24, 2026 close $39.41 → Oct 29, 2026 close $29.64. S&P 500 +4.5% over the same days.
SoldImmunovant
$57K
Jun 26, 2026 close $38.85 → Oct 29, 2026 close $29.64. S&P 500 +5.9% over the same days.
SoldImmunovant
$51K
Jun 15, 2026 close $33.44 → Oct 29, 2026 close $29.64. S&P 500 +2.3% over the same days.
SoldImmunovant
$192K
May 20, 2026 close $35.56 → Oct 29, 2026 close $29.64. S&P 500 +4.2% over the same days.